A cost calculation model for specialist palliative care for patients with non-small cell lung cancer in a tertiary centre

Author： Ostgathe Christoph  

Publisher： Springer Publishing Company

ISSN： 0941-4355

Source： Supportive Care in Cancer, Vol.16, Iss.5, 2008-05, pp. : 501-506

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Quality of life in advanced non-small cell lung cancer patients receiving palliative chemotherapy: A meta-analysis of randomized controlled trials

By      

Experimental and Therapeutic Medicine, Vol. 3, Iss. 1, 2012-01 ,pp. : 134-140

Spandidos Publications

Access to resources Recommend Favorite

Adjuvant chemotherapy for non-small cell lung cancer: the new standard of care

By Laskin Janessa J  

Future Oncology, Vol. 1, Iss. 5, 2005-10 ,pp. : 619-623

Future Medicine

Access to resources Recommend Favorite

Validation of a clinical prognostic model in Chinese patients with metastatic and advanced pretreated non-small cell lung cancer treated with gefitinib

By Wang Fenghua  

Medical Oncology, Vol. 28, Iss. 1, 2011-03 ,pp. : 331-335

Humana Press, Inc

Access to resources Recommend Favorite

Effects of Gemcitabine on renal function in patients with non-small cell lung cancer

By Gietema J.A.   Groen H.J.M.   Meijer S.   Smit E.F.  

European Journal of Cancer, Vol. 34, Iss. 1, 1998-01 ,pp. : 199-202

Elsevier

Access to resources Recommend Favorite

Gemictabine plus carboplatin in patients with advanced non-small cell lung cancer

By Park Se   Jeong Seong   Kyung Sun   Lim Young-Hee   An Chang   Lee Sang   Park Jeong   Bang Soo   Cho Eun   Shin Dong   Lee Jae  

Medical Oncology, Vol. 22, Iss. 4, 2005-12 ,pp. : 359-366

Humana Press, Inc

Access to resources Recommend Favorite